It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
Lixisenatide requires daily injections, while newer GLP-1-targeting drugs like Ozempic and ... injections with lixisenatide to a placebo shot, with the primary endpoint the change from baselines ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
They're known to aid in blood sugar control and, now, weight loss — however, according to a sweeping new study, the popular ...
Can GLP-1 Meds Harm Your Eyes? By Ernie Mundell HealthDay Reporter MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss ...
Now, diabetes specialists and cardiologists are among the specialists flocking to GLP-1 drugs to manage blood sugar and weight. In many ways, it's easier for physicians to access these drugs.
Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person’s chance ...
But virtual diabetes and weight management care changed when GLP-1 drug Wegovy was approved for weight loss in June 2021. As the drugs' popularity reached new heights, it became an expensive item ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results